Prevalence of cardiometabolic risk factors in hispanics living with HIV

Ethnicity and Disease

Volumn 20, Issue 4, 2010, Pages 423-428

  Ramírez Marrero, Farah A ^a   De Jesuś, Eilyn ^b   Santana Bagur, Jorge ^a   Hunter, Robert ^b   Frontera, Walter ^a   Joyner, Michael J ^c  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b SCHOOL OF MEDICINE   (Puerto Rico)

^c Mayo Clinic College of Medicine   (Puerto Rico)

Author keywords

Hispanics; HIV; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIRETROVIRUS AGENT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATION; FEMALE; FISHER EXACT TEST; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIXED INFECTION; PREVALENCE; PUERTO RICO; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VIRUS LOAD; WAIST CIRCUMFERENCE; ALGORITHM; CARDIOVASCULAR DISEASE; ETHNOLOGY; MIDDLE AGED; OBESITY; RISK FACTOR; STATISTICAL MODEL;

ADULT; ALGORITHMS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; PUERTO RICO; RISK FACTORS;

EID: 79952684012     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Falutz J. Therapy insight: Body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy. Nat Clin Pract Endocrinol Metab. 2007;3(9):651-661. (Pubitemid 47294430)
2. Morse C.G., Kovacs J.A. Metabolic and skeletal complications of HIV infection: The price of success. JAMA. 2006;296(7):844-854. (Pubitemid 44223107)
3. Centers for Disease Control and Prevention. Prevalence of diabetes among Hispanics - Selected areas, 1998-2002. MMWR Morb Mortal Wkly Rep. 2004;53(40):941-944.
4. Centers for Disease Control and Prevention. Hypertension-related mortality among Hispanic subpopulations. MMWR Morb Mortal Wkly Rep. 2006;55(07):177-180.
5. Ervin R.B. Prevalence of Metabolic Syndrome among Adults 20 Years of Age and Over, by Sex, Age, Race and Ethnicity, and Body Mass Index: United States, 2003-2006. Hyattsville, Md: National Center for Health Statistics; 2009.
6. Pérez C.M., Guzmán M., Ortiz A.P., et al. Prevalence of the metabolic syndrome in San Juan, Puerto Rico. Ethn Dis. 2008;18(4):434-441.
7. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359. (Pubitemid 34251969)
8. Escobedo J., Schargrodsky H., Champagne B., et al.Prevalence of themetabolic syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: The CARMELA cross sectional study. Cardiovasc Diabetol. 2009;8:52.
9. Puerto Rico Health Department. Puerto Rico AIDS Surveillance Program Report. San Juan: Puerto Rico Health Department; 2009.
10. Executive Summary Of The Third Report Of The National Cholesterol Education Program (NCEP) Expert Panel On Detection, Evaluation, And Treatment Of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001;(285):2486-2497.
11. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev. 2005;13(6):322-327. (Pubitemid 41579599)
12. Jacobson D.L., Tang A.M., Spiegelman D., et al. Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey). J Acquir Immune Defic Syndr. 2006;43(4):458-466. (Pubitemid 44737105)
13. Mondy K., Overton E.T., Grubb J., et al. Metabolic syndrome in HIV-infected patients from an urban, Midwestern US outpatient population. Clin Infect Dis. 2007;44(5):726-734.
14. Samaras K., Wand H., Law M., Emery S., Cooper D., Carr A. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Diabetes Care. 2007;30(1):113-119. (Pubitemid 46052508)
15. Jerico C., Knobel H., Montero M., et al. Metabolic syndrome among HIV-infected patients: Prevalence, characteristics, and related factors. Diabetes Care. 2005;28(1):132-137. (Pubitemid 40095795)
16. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. 2005. Available at: www.cdc.gov/brfss. Last accessed October 4, 2010.
17. Pao V., Lee G.A., Grunfeld C. HIV therapy, metabolic syndrome, and cardiovascular risk. Curr Atheroscler Rep. 2008;10(1):61-70. (Pubitemid 351385601)
18. Amorosa V., Synnestvedt M., Gross R., et al. A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. J Acquir Immune Defic Syndr. 2005;39(5):557-561. (Pubitemid 41098470)
19. Danoff A., Shi Q., Justman J., et al. Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women. J Acquir Immune Defic Syndr. 2005;39(1):55-62. (Pubitemid 40617019)
20. Batsis J.A., Nieto-Martinez R.E., Lopez-Jimenez F. Metabolic syndrome: From global epidemiology to individualized medicine. Clin Pharmacol Ther. 2007;82(5):509-524. (Pubitemid 47622528)
21. Salyer J., Lyon D.E., Settle J., Elswick R.K., Rackley D. Coronary heart disease risks and lifestyle behaviors in persons with HIV infection. J Assoc Nurses AIDS Care. 2006;17(3):3-17. (Pubitemid 43900470)
22. Sobieszczyk M.E., Hoover D.R., Anastos K., et al. Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr. 2008;48(3):272-280.
23. Squillace N., Zona S., Stentarelli C., et al. Detectable HIV viral load is associated with metabolic syndrome. J Acquir Immune Defic Syndr. 2009;52(4):459-464.
24. Bergersen B.M., Schumacher A., Sandvik L., Bruun J.N., Birkeland K. Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls. Scand J Infect Dis. 2006;38(8):682-689. (Pubitemid 44144728)